1. Boehringer Ingelheim International Gmbh (30 from 1,536 patents)

2. Abbvie Deutschland Gmbh and Co Kg (13 from 167 patents)

3. Abbott Gmbh & Co Kg (13 from 139 patents)

4. Abbott Laboratories Corporation (3 from 4,179 patents)

5. Other (1 from 832,843 patents)

6. Abbott Gmbh & Co. Hg (1 from 1 patent)

7. Gb007, Inc. (0 patent)

1. 12065427 - Heterocyclic compounds capable of activating STING

2. 11878981 - Substituted 1,2,4-oxadiazoles as TRPA1 inhibitors

3. 10537590 - Cyclic dinucleotide compounds

4. 10392419 - Modified cyclic dinucleotide compounds

5. RE47493 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

6. 10238633 - Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of Cathepsin C

7. RE46630 - Substituted 4-pyridones and their use as inhibitors of neutrophil elastase activity

8. 9713606 - Methods for treating pulmonary emphysema using substituted 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)-amides inhibitors of cathepsin C

9. 9670166 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

10. 9657015 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

11. 9487505 - Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

12. 9475779 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

13. 9458113 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

14. 9440930 - Substituted bicyclic dihydropyrimidinones and their use as inhibitors of neutrophil elastase activity

15. 9434713 - 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases